Dr. Antoinette Moran is Division Head of Pediatric Endocrinology and Diabetes. She leads an international multicenter trial of the use of diabetes therapy to improve muscle mass in cystic fibrosis patients with abnormal glucose tolerance, and is conducting extensive metabolic studies of protein, lipid and carbohydrate turnover in this population. Dr. Moran is a principal investigator for the TrialNet diabetes prevention study, and as part of that network is participating in several trials to prevent or ameliorate new onset type 1 diabetes. In her role as Director of the Metabolic Core of the Islet Transplant program she directs the assessment of metabolic endpoints to improve the efficacy of islet transplantation of type 1 diabetes.
View Dr. Moran's selected publications